Director at First Tracks Biotherapeutics (TRAXV) receives new equity grants
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
First Tracks Biotherapeutics director Magda Marquet reported new equity awards and spin-off related holdings. She holds 9,930 shares of common stock received in the pro rata distribution from AnaptysBio under the Separation and Distribution Agreement. On the derivative side, she was granted 4,000 restricted stock units that vest in full on the company’s 2026 annual meeting date and 6,030 RSUs that vest in full on the 2027 annual meeting date, each RSU convertible into one common share for no cash payment. She also holds multiple stock options to buy First Tracks common stock, including 5,500 options at an exercise price of $11.75 per share that are fully vested and 16,510 options at $3.97 per share that vest monthly over 12 months starting February 6, 2026, along with several older option grants at exercise prices between $6.22 and $8.14 per share.
Positive
- None.
Negative
- None.
Insider Trade Summary
10 transactions reported
Mixed
10 txns
Insider
Marquet Magda
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 784 | $0.00 | -- |
| Grant/Award | Stock Option (right to buy) | 11,000 | $0.00 | -- |
| Grant/Award | Stock Option (right to buy) | 9,200 | $0.00 | -- |
| Grant/Award | Stock Option (right to buy) | 10,600 | $0.00 | -- |
| Grant/Award | Stock Option (right to buy) | 16,510 | $0.00 | -- |
| Grant/Award | Stock Option (right to buy) | 16,510 | $0.00 | -- |
| Grant/Award | Stock Option (right to buy) | 5,500 | $0.00 | -- |
| Grant/Award | Restricted Stock Unit | 6,030 | $0.00 | -- |
| Grant/Award | Restricted Stock Unit | 4,000 | $0.00 | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Stock Option (right to buy) — 784 shares (Direct, null);
Restricted Stock Unit — 6,030 shares (Direct, null);
Common Stock — 9,930 shares (Direct, null)
Footnotes (1)
- Consists of shares of common stock received in connection with the spin-off of First Tracks Biotherapeutics, Inc. ("First Tracks") from AnaptysBio, Inc. ("AnaptysBio"). Effective as of a pro rata distribution by AnaptysBio to holders of its shares of common stock pursuant to the Separation and Distribution Agreement dated as of April 20, 2026, by and between AnaptysBio and First Tracks (the "Separation Agreement"), each outstanding option to acquire AnaptysBio shares of common stock was adjusted so that such option became an option to acquire First Tracks shares of common stock and an option to acquire AnaptysBio shares of common stock. As a result, the Reporting Person acquired options to acquire First Tracks shares of common stock in an amount determined in accordance with the Separation Agreement. The stock option is fully vested and exercisable. The stock option vests as to 1/12 of the total shares monthly commencing on February 6, 2026 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. Effective as of a pro rata distribution by AnaptysBio to holders of its shares of common stock pursuant to the Separation Agreement, each outstanding RSU with respect to AnaptysBio shares of common stock was adjusted so that such RSU became an RSU with respect to First Tracks shares of common stock and an RSU with respect to AnaptysBio's shares of common stock. As a result, the Reporting Person acquired RSU s with respect to First Tracks shares of common stock in an amount determined in accordance with the Separation Agreement. The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2026 annual meeting of shareholders, subject to the Reporting Person's provision of service to the Issuer on each vesting date. The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2027 annual meeting of shareholders, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
Key Figures
Common stock holdings: 9,930 shares
RSU grant 2026 meeting: 4,000 RSUs
RSU grant 2027 meeting: 6,030 RSUs
+5 more
8 metrics
Common stock holdings
9,930 shares
Shares of common stock held directly after spin-off distribution
RSU grant 2026 meeting
4,000 RSUs
Vests 100% on date of 2026 annual shareholder meeting
RSU grant 2027 meeting
6,030 RSUs
Vests 100% on date of 2027 annual shareholder meeting
Option position fully vested
5,500 options at $11.75/share
Stock option fully vested and exercisable to buy common stock
Option grant at $3.97
16,510 options at $3.97/share
Stock option vesting monthly over 12 months from February 6, 2026
Option grant at $5.67
16,510 options at $5.67/share
Stock option to acquire common stock, expiration January 2, 2034
Option grant at $6.22
10,600 options at $6.22/share
Stock option to acquire common stock, expiration January 5, 2033
Option grant at $8.14
9,200 options at $8.14/share
Stock option to acquire common stock, expiration February 9, 2032
Key Terms
Restricted Stock Unit, Stock Option (right to buy, Separation and Distribution Agreement, pro rata distribution, +2 more
6 terms
Restricted Stock Unit financial
"Each restricted stock unit ("RSU") represents a contingent right"
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
Stock Option (right to buy financial
"Stock Option (right to buy) ... option to acquire First Tracks shares"
Separation and Distribution Agreement regulatory
"pursuant to the Separation and Distribution Agreement dated as of April 20, 2026"
pro rata distribution financial
"Effective as of a pro rata distribution by AnaptysBio to holders"
A pro rata distribution is when a company or organization shares out money, assets, or benefits evenly among all eligible people based on their size or share. For example, if a company makes a profit and distributes it to shareholders, each person gets a portion proportional to how many shares they own. It ensures everyone gets their fair part based on their ownership or stake.
vests as to 1/12 financial
"The stock option vests as to 1/12 of the total shares monthly"
FAQ
What equity awards did Magda Marquet report in this Form 4 for TRAXV?
Magda Marquet reported grants of restricted stock units and stock options. She received 4,000 RSUs and 6,030 RSUs plus several stock option positions to purchase First Tracks common stock at exercise prices between $3.97 and $11.75 per share.
How do Magda Marquet’s restricted stock units in TRAXV vest?
Her 4,000 RSUs vest 100% on the date of First Tracks’ 2026 annual shareholder meeting. The 6,030 RSUs vest 100% on the date of the 2027 annual shareholder meeting, in each case contingent on continued service to the company.
What are the key terms of Magda Marquet’s stock options in First Tracks Biotherapeutics?
She holds several stock option grants, including 5,500 options at $11.75 per share that are fully vested. Additional grants cover 16,510 shares at $3.97, 16,510 at $5.67, and other amounts with exercise prices between $6.22 and $8.14 per share.
How were Magda Marquet’s TRAXV options and RSUs affected by the AnaptysBio spin-off?
Each outstanding AnaptysBio option and RSU was adjusted so it became an award in both AnaptysBio and First Tracks. As a result, she acquired First Tracks options and RSUs in amounts determined under the Separation and Distribution Agreement.